TrialInfluenza and other respiratory viruses2020

Clinical phase II and III studies of an AS03-adjuvanted H5N1 influenza vaccine produced in an EB66

Masafumi Endo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.